Chemoinformaics analysis of 3-Butenyl isothiocyanate
| Molecular Weight | 113.185 | nRot | 3 |
| Heavy Atom Molecular Weight | 106.129 | nRig | 3 |
| Exact Molecular Weight | 113.03 | nRing | 0 |
| Solubility: LogS | -2.139 | nHRing | 0 |
| Solubility: LogP | 2.551 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 17.0176 |
| nHD | 0 | BPOL | 9.39245 |
| QED | 0.235 |
| Synth | 4.007 |
| Natural Product Likeliness | 1.439 |
| NR-PPAR-gamma | 0.981 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.401 |
| MDCK | 0.000032 |
| BBB | 0.238 |
| PPB | 0.353254 |
| VDSS | 1.699 |
| FU | 0.669826 |
| CYP1A2-inh | 0.204 |
| CYP1A2-sub | 0.345 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.524 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.101 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.74 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.264 |
| CL | 7.307 |
| T12 | 0.657 |
| hERG | 0.003 |
| Ames | 0.311 |
| ROA | 0.959 |
| SkinSen | 0.937 |
| Carcinogencity | 0.733 |
| EI | 0.988 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.838 |
| Antiviral | No |
| Prediction | 0.954861 |